Expression of tissue transglutaminase and elafin in human coronary artery
- 1 January 2002
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 160 (1) , 31-39
- https://doi.org/10.1016/s0021-9150(01)00542-1
Abstract
No abstract availableKeywords
Funding Information
- Uehara Memorial Foundation (12877109, B12470154, C11670679, C12835007)
- Ministry of Education, Culture, Sports, Science and Technology
- Ono Medical Research Foundation
- Japan Heart Foundation
- Suzuken Memorial Foundation
This publication has 25 references indexed in Scilit:
- An Intronic NF-kappaB Element Is Essential for Induction of the Human Manganese Superoxide Dismutase Gene by Tumor Necrosis Factor-alpha and Interleukin-1betaDNA and Cell Biology, 1999
- TNF-α–Induced Migration of Vascular Smooth Muscle Cells Is MAPK DependentHypertension, 1999
- Lipid Lowering by Diet Reduces Matrix Metalloproteinase Activity and Increases Collagen Content of Rabbit AtheromaCirculation, 1998
- Tumor Necrosis Factor-α Activates Smooth Muscle Cell Migration in Culture and Is Expressed in the Balloon-Injured Rat AortaArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Human Monocytes/Macrophages Release TNF-α in Response to Ox-LDLArteriosclerosis, Thrombosis, and Vascular Biology, 1996
- Mast Cells in Rupture-Prone Areas of Human Coronary Atheromas Produce and Store TNF-αCirculation, 1996
- Isolation and Characterization of the Human Tissue Transglutaminase Gene PromoterPublished by Elsevier ,1995
- Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)The Lancet, 1994
- Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease.Circulation, 1993
- Increased transglutaminase in the aortas of cholesterol-fed rabbits: occurrence of buffer soluble and insoluble forms and an inhibitorBiochemistry and Cell Biology, 1991